M0430
甲基纤维素
meets USP testing specifications, 26.0-33.0% (methoxyl group, on Dry Basis), viscosity: 400 cP
产品名称
甲基纤维素, meets USP testing specifications, 26.0-33.0% (methoxyl group, on Dry Basis), viscosity: 400 cP
SMILES string
[*]OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO[*])O[C@@H](O[*])[C@H](O[*])[C@H]2O[*])[C@H](O[*])[C@@H](O[*])[C@@H]1O[*]
InChI key
YLGXILFCIXHCMC-JHGZEJCSSA-N
agency
USP/NF
meets USP testing specifications
assay
26.0-33.0% (methoxyl group, on Dry Basis)
form
powder
useful pH range
5.0-8.0 (2% in water)
viscosity
320-480 cP, 2 % in water(20 °C)
application(s)
pharmaceutical (small molecule)
Quality Level
正在寻找类似产品? 访问 产品对比指南
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves
Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission
Snyder GL, et al.
Psychopharmacology, 232(3), 605-621 (2015)
In Vitro and In Vivo Characterization of PCC0104005, a Novel Modulator of Serotonin-Dopamine Activity, as an Atypical Antipsychotic Drug
Xu Y,et al.
Scientific Reports, 8(1), 6892-6892 (2018)
Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance
Li S, et al.
Breast Cancer Research, 17(1), 91-91 (2015)
Handbook of Adhesives and Surface Preparation (2011)
Yanan Xu et al.
Scientific reports, 8(1), 6892-6892 (2018-05-04)
PCC0104005 is a novel drug candidate for treating schizophrenia that displays high affinity for serotonin, dopamine, and noradrenaline receptors, including partial agonism at dopamine D2, D3, D4, serotonin 5-HT1A, and 5-HT2A receptors and antagonism at 5-HT2B, 5-HT6, and 5-HT7 receptors.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持